These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

160 related items for PubMed ID: 28434367

  • 1. A late-onset case of hereditary transthyretin amyloidosis with a novel compound heterozygous mutation.
    Matsumoto S, Ueda M, Yamashita T, Amano T, Misumi Y, Tasaki M, Masuda T, Mizukami M, Furuya H, Ando Y.
    Amyloid; 2017 Mar; 24(sup1):97-98. PubMed ID: 28434367
    [No Abstract] [Full Text] [Related]

  • 2. Common clinicopathological features in late-onset hereditary transthyretin amyloidosis (Ala97Gly, Val94Gly and Val30Met).
    Koike H, Nakamura T, Nishi R, Ikeda S, Kawagashira Y, Iijima M, Yasuda T, Mukai E, Date Y, Shiomi K, Nakazato M, Katsuno M, Sobue G.
    Amyloid; 2019 Mar; 26(sup1):24-25. PubMed ID: 31343348
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Systemic angiopathy and axonopathy in hereditary transthyretin amyloidosis with Ala97Gly (p. Ala117Gly) mutation: a post-mortem analysis.
    Koike H, Yasuda T, Nishi R, Ikeda S, Kawagashira Y, Iijima M, Sobue G, Katsuno M.
    Amyloid; 2018 Jun; 25(2):141-142. PubMed ID: 29855203
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Effects of liver transplantation and tafamidis in hereditary transthyretin amyloidosis caused by transthyretin Leu55Pro mutation: a case report.
    Kon T, Misumi Y, Nishijima H, Honda M, Suzuki C, Baba M, Inomata Y, Obayashi K, Ando Y, Tomiyama M.
    Amyloid; 2015 Jun; 22(3):203-4. PubMed ID: 26123280
    [No Abstract] [Full Text] [Related]

  • 15. Amyloid Polyneuropathy and Myocardial Amyloidosis 10 Years after Domino Liver Transplantation from a Patient with a Transthyretin Ser50Arg Mutation.
    Matsushima M, Yabe I, Tsuda M, Sakakibara M, Shimamura T, Sasaki H.
    Intern Med; 2017 Dec 01; 56(23):3231-3235. PubMed ID: 28943540
    [Abstract] [Full Text] [Related]

  • 16. Rapidly Progressive Transthyretin-Mediated Amyloidosis in a Domino Liver Transplant Recipient of a Ser23Asn Donor.
    Dixit N, Castano A, Farr MJ, Traub R, Lentzsch S, Brown RS, Maurer MS, Brannagan TH.
    J Clin Neuromuscul Dis; 2016 Mar 01; 17(3):142-5. PubMed ID: 26905915
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Rapid detection of wild-type and mutated transthyretins.
    Tasaki M, Ueda M, Obayashi K, Motokawa H, Kinoshita Y, Suenaga G, Yanagisawa A, Toyoshima R, Misumi Y, Masuda T, Yamashita T, Ando Y.
    Ann Clin Biochem; 2016 Jul 01; 53(Pt 4):508-10. PubMed ID: 26342004
    [Abstract] [Full Text] [Related]

  • 20. RNA interference in late-stage hereditary transthyretin amyloidosis: a clinicopathological study.
    Beck G, Yonenobu Y, Kawai M, Ikenaka K, Sera F, Ozono T, Shimada Y, Yamashita R, Sakata Y, Morii E, Yoshinaga T, Ando Y, Murayama S, Mochizuki H.
    J Neurol; 2023 Sep 01; 270(9):4544-4548. PubMed ID: 37154892
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.